Growing insights into the functionality of lectin-carbohydrate interactions are identifying attractive new targets for drug design. As glycan recognition is regulated by the structure of the sugar epitope and also by topological aspects of its presentation, a suitable arrangement of ligands in synthetic glycoclusters has the potential to enhance their avidity and selectivity. If adequately realized, such compounds might find medical applications. This is why we focused on lectins of clinical interest, acting either as a potent biohazard (a toxin from Viscum album L. akin to ricin) or as a factor in tumor progression (human galectins-1, -3, and -4). Using a set of 14 calix[n]arenes (n=4, 6, and 8) with thiourea-linked galactose or lactose moieties, we first ascertained the lectin-binding properties of the derivatized sugar head groups conjugated to the synthetic macrocycles. Despite their high degree of flexibility, the calix[6,8]arenes proved especially effective for the plant AB-toxin, in the solid-phase model system with a single glycoprotein (asialofetuin) and with human tumor cells in vitro. The bioactivity of the calix[n]arenes was also proven for human galectins. Notably, selectivity for the tested tandem-repeat-type galectin-4 among the three subgroups was determined at the level of solid-phase and cell assays, the large flexible macrocycles again figuring prominently as inhibitors. Alternate and cone versions of calix[4]arene with lactose units distinguished between galectins-1 and -4 versus galectin-3 in cell assays. The results thus revealed bioactivity of galactose-/lactose-presenting calix[n]arenes for medically relevant lectins and selectivity within the family of adhesion/growth-regulatory human galectins.

Calix[n]arene-based Glycoclusters: Bioactivity of Thiourea-linked Galactose/lactose moieties as inhibitors of binding of medically relevant lectins to a glycoprotein and cell surface glycoconjugates and selectivity among human adhesion/growth regulatory galectins / S., André; Sansone, Francesco; H., Kaltner; Casnati, Alessandro; J., Kopitz; H. J., Gabius; Ungaro, Rocco. - In: CHEMBIOCHEM. - ISSN 1439-4227. - 9:(2008), pp. 1649-1661. [10.1002/cbic.200800035]

Calix[n]arene-based Glycoclusters: Bioactivity of Thiourea-linked Galactose/lactose moieties as inhibitors of binding of medically relevant lectins to a glycoprotein and cell surface glycoconjugates and selectivity among human adhesion/growth regulatory galectins

SANSONE, Francesco;CASNATI, Alessandro;UNGARO, Rocco
2008-01-01

Abstract

Growing insights into the functionality of lectin-carbohydrate interactions are identifying attractive new targets for drug design. As glycan recognition is regulated by the structure of the sugar epitope and also by topological aspects of its presentation, a suitable arrangement of ligands in synthetic glycoclusters has the potential to enhance their avidity and selectivity. If adequately realized, such compounds might find medical applications. This is why we focused on lectins of clinical interest, acting either as a potent biohazard (a toxin from Viscum album L. akin to ricin) or as a factor in tumor progression (human galectins-1, -3, and -4). Using a set of 14 calix[n]arenes (n=4, 6, and 8) with thiourea-linked galactose or lactose moieties, we first ascertained the lectin-binding properties of the derivatized sugar head groups conjugated to the synthetic macrocycles. Despite their high degree of flexibility, the calix[6,8]arenes proved especially effective for the plant AB-toxin, in the solid-phase model system with a single glycoprotein (asialofetuin) and with human tumor cells in vitro. The bioactivity of the calix[n]arenes was also proven for human galectins. Notably, selectivity for the tested tandem-repeat-type galectin-4 among the three subgroups was determined at the level of solid-phase and cell assays, the large flexible macrocycles again figuring prominently as inhibitors. Alternate and cone versions of calix[4]arene with lactose units distinguished between galectins-1 and -4 versus galectin-3 in cell assays. The results thus revealed bioactivity of galactose-/lactose-presenting calix[n]arenes for medically relevant lectins and selectivity within the family of adhesion/growth-regulatory human galectins.
2008
Calix[n]arene-based Glycoclusters: Bioactivity of Thiourea-linked Galactose/lactose moieties as inhibitors of binding of medically relevant lectins to a glycoprotein and cell surface glycoconjugates and selectivity among human adhesion/growth regulatory galectins / S., André; Sansone, Francesco; H., Kaltner; Casnati, Alessandro; J., Kopitz; H. J., Gabius; Ungaro, Rocco. - In: CHEMBIOCHEM. - ISSN 1439-4227. - 9:(2008), pp. 1649-1661. [10.1002/cbic.200800035]
File in questo prodotto:
File Dimensione Formato  
ChemBioChemGabius.pdf

non disponibili

Tipologia: Documento in Post-print
Licenza: Creative commons
Dimensione 742.39 kB
Formato Adobe PDF
742.39 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
chembiochem Gabius SI.pdf

non disponibili

Tipologia: Documento in Post-print
Licenza: Creative commons
Dimensione 210.71 kB
Formato Adobe PDF
210.71 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
ChemBioChemGabius cover.pdf

non disponibili

Tipologia: Documento in Post-print
Licenza: Creative commons
Dimensione 1.47 MB
Formato Adobe PDF
1.47 MB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/1834210
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 142
  • ???jsp.display-item.citation.isi??? 131
social impact